John Michael Middlecott Banham's Net Worth

$844 Thousand

Estimate Recalculated May 30, 2025 08:59PM EST

Who is John Michael Middlecott Banham?

John Michael Middlecott Banham does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Invesco Ltd., and Cyclacel Pharmaceuticals, Inc..

SEC CIK

John Michael Middlecott Banham's CIK is 0001357635

Past Insider Trading and Trends

2008 was John Michael Middlecott Banham's most active year for acquiring shares with 5 total transactions. John Michael Middlecott Banham's most active month to acquire stocks was the month of April. 2013 was John Michael Middlecott Banham's most active year for disposing of shares, totalling 2 transactions. John Michael Middlecott Banham's most active month to dispose stocks was the month of April. 2006 saw John Michael Middlecott Banham paying a total of $140,510.00 for 55,597 shares, this is the most they've acquired in one year. In 2013 John Michael Middlecott Banham cashed out on 12,475 shares for a total of $420,942.05, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Invesco Ltd. (IVZ) Snapshot price: $15.74

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+5.28%
1.01K
—
—
20.11K
May 2
Form 4
+3.88%
714
—
—
19.1K
Jan 31
Form 4
-17.77%
-3.98K
$33.79
-$134,315.25
18.39K
Nov 15
Form 4
+3.24%
701
—
—
22.36K
Nov 1
Form 4
+3.43%
718
—
—
21.66K
Aug 1
Form 4
-28.87%
-8.50K
$33.72
-$286,626.80
20.95K
May 10
Form 4
+2.63%
755
—
—
29.45K
May 1
Form 4
+3.07%
855
—
—
28.69K
Feb 1
Form 4
+3.62%
973
—
—
27.84K
Nov 2
Form 4
-8.05%
-2.35K
$23.51
-$55,330.56
26.86K
Aug 24
Form 4
+3.81%
1.07K
—
—
29.22K
Jul 27
Form 4
+3.48%
946
—
—
28.14K
Apr 27
Form 4
+3.95%
1.03K
—
—
27.2K
Jan 27
Form 4
+5.07%
1.26K
—
—
26.16K
Oct 25
Form 4
+4.47%
1.07K
—
—
24.9K
Jul 27
Form 4
+4.16%
951
—
—
23.84K
Apr 28
Form 4
+4.39%
963
—
—
22.88K
Jan 28
Form 4
+5.09%
1.06K
—
—
21.92K
Oct 26
Form 4
+6.26%
1.23K
—
—
20.86K
Jul 28
Form 4
+5.38%
1K
—
—
19.63K
Apr 29
Form 4
+5.11%
906
—
—
18.63K
Jan 29
Form 4
+4.52%
767
—
—
17.72K
Oct 21
Form 4
+5.71%
916
—
—
16.95K
Jul 28
Form 4
+8.03%
1.19K
—
—
16.04K
Apr 24
Form 4
+10.42%
1.4K
—
—
14.85K
Feb 2
Form 4
+9.95%
1.22K
—
—
13.45K
Oct 30
Form 4
+6.88%
787
—
—
12.23K
Jul 25
Form 4
+6.66%
714
—
—
11.44K
May 16
Form 4
+17.44%
1.59K
—
—
10.73K
Feb 20
Form 3
—
0
—
—
0
No matching records found

Cyclacel Pharmaceuticals, Inc. (CYCC) Snapshot price: $1.02

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 25
Form 4
—
0
—
—
0
May 29
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
May 30
Form 4
—
0
—
—
0
May 26
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
May 23
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
Mar 29
Form 4
—
0
—
—
0
Mar 27
Form 4
—
0
—
—
0
Feb 19
Form 4
—
0
—
—
0
Mar 9
Form 4
+10.50%
3.5K
$5.86
$20,510.00
36.85K
Sep 7
Form 4
—
0
—
—
0
Jun 14
Form 4
∞
33.35K
—
—
33.35K
Mar 27
Form 3
—
0
—
—
0
No matching records found